Societal CDMO Competitors and Similar CompaniesClear all

Biofrontera's competitors and similar companies include Amicus Therapeutics.
Biofrontera
Biofrontera
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Founding Date
Founding Date
2012
Founding Date
2002
Type
Type
Public
Type
Public
Tags
Locations
Locations
Leverkusen, DE HQ
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Employees
Employees
91
Employees
58415% increase
Valuation ($)
Valuation ($)
1.1 m
Valuation ($)
3.4 b

Financial

Revenue (est.)
Revenue (est.)
€13.2m (FY, 2025)
Revenue (est.)
$634.2m (FY, 2025)
Cost of goods
Cost of goods
€2.2m (FY, 2025)
Cost of goods
$72.9m (FY, 2025)
Gross profit
Gross profit
€11.2m (FY, 2025)
Gross profit
$561.3m (FY, 2025)
Net income
Net income
(€6.9m) (FY, 2025)
Net income
($27.1m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company